567 related articles for article (PubMed ID: 17149362)
21. Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion.
Xie Z; Choong PF; Poon LF; Zhou J; Khng J; Jasinghe VJ; Palaniyandi S; Chen CS
Cancer Chemother Pharmacol; 2008 Nov; 62(6):949-57. PubMed ID: 18259754
[TBL] [Abstract][Full Text] [Related]
22. Reduction of liver tumor necrosis factor-alpha expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis.
Dong L; Zuo L; Xia S; Gao S; Zhang C; Chen J; Zhang J
J Gene Med; 2009 Mar; 11(3):229-39. PubMed ID: 19189285
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
[TBL] [Abstract][Full Text] [Related]
24. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
Fukuma T; Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
[TBL] [Abstract][Full Text] [Related]
25. gp130-specific antisense oligonucleotides inhibit IL-6 signal inducing junB mRNA transcription in the human hepatoma cell line, HepG2.
Varga VL; Fülöp AK; Holub MC; Tóth S; Szalai C; Falus A
Cell Biol Int; 2001; 25(8):835-40. PubMed ID: 11482910
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis of drug-resistant human ovarian carcinoma cell line COC1/DDP induced by survivin antisense oligonucleotides.
Zheng F; Ruan F; Xie XK; Liu SY
Chin Med J (Engl); 2006 Sep; 119(18):1572-5. PubMed ID: 16996013
[No Abstract] [Full Text] [Related]
27. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model.
Yamanaka K; Gleave M; Muramaki M; Hara I; Miyake H
Oncol Rep; 2005 May; 13(5):885-90. PubMed ID: 15809754
[TBL] [Abstract][Full Text] [Related]
28. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions.
Chan JH; Liao W; Lau HY; Wong WS
Int Immunopharmacol; 2007 Jul; 7(7):937-44. PubMed ID: 17499196
[TBL] [Abstract][Full Text] [Related]
29. Biological function of a novel gene overexpressed in human hepatocellular carcinoma.
Liu J; Zhou R; Zhang N; Rui J; Jin C
Chin Med J (Engl); 2000 Oct; 113(10):881-5. PubMed ID: 11775832
[TBL] [Abstract][Full Text] [Related]
30. Antisense oligonucleotides: from design to therapeutic application.
Chan JH; Lim S; Wong WS
Clin Exp Pharmacol Physiol; 2006; 33(5-6):533-40. PubMed ID: 16700890
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of bacterial RNase P RNA as a drug target.
Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
Cheng B; Yang X; Han Z; An L; Liu S
Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
35. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.
Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP
Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810
[TBL] [Abstract][Full Text] [Related]
36. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
37. Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models.
Rödel F; Frey B; Leitmann W; Capalbo G; Weiss C; Rödel C
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):247-55. PubMed ID: 18406888
[TBL] [Abstract][Full Text] [Related]
38. Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.
Yu RZ; Lemonidis KM; Graham MJ; Matson JE; Crooke RM; Tribble DL; Wedel MK; Levin AA; Geary RS
Biochem Pharmacol; 2009 Mar; 77(5):910-9. PubMed ID: 19056355
[TBL] [Abstract][Full Text] [Related]
39. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
40. Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms.
Vickers TA; Crooke ST
PLoS One; 2014; 9(10):e108625. PubMed ID: 25299183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]